Cargando…
Insulin Requirements in Untreated Acromegaly: From 200 to 0
We describe a patient with acromegaly presenting in diabetic ketoacidosis who was able to achieve euglycemia despite discontinuation of all antihyperglycemic therapy prior to surgical or medical treatment for his acromegaly. No previous cases of acromegaly presenting in diabetic ketoacidosis have re...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578379/ https://www.ncbi.nlm.nih.gov/pubmed/37908250 http://dx.doi.org/10.1210/jcemcr/luac007 |
_version_ | 1785121507282780160 |
---|---|
author | Goldstein, Michael B Bellavia, Lauren Kurian, Tiffany Klek, Stanislaw |
author_facet | Goldstein, Michael B Bellavia, Lauren Kurian, Tiffany Klek, Stanislaw |
author_sort | Goldstein, Michael B |
collection | PubMed |
description | We describe a patient with acromegaly presenting in diabetic ketoacidosis who was able to achieve euglycemia despite discontinuation of all antihyperglycemic therapy prior to surgical or medical treatment for his acromegaly. No previous cases of acromegaly presenting in diabetic ketoacidosis have reported glycemic normalization without antihyperglycemic therapy prior to acromegaly treatment. Our case highlights this unique outcome and postulates that pancreatic β-cell resiliency may be influential on insulin resistance since our patient achieved euglycemia despite a persistent state of excess growth hormone and insulin-like growth factor-1. Our case further emphasizes that consideration for acromegaly should be given in patients presenting with severe insulin resistance and pertinent medical history and physical examination features, and it emphasizes the dramatic range of insulin requirements in patients with acromegaly. |
format | Online Article Text |
id | pubmed-10578379 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-105783792023-10-31 Insulin Requirements in Untreated Acromegaly: From 200 to 0 Goldstein, Michael B Bellavia, Lauren Kurian, Tiffany Klek, Stanislaw JCEM Case Rep Case Report We describe a patient with acromegaly presenting in diabetic ketoacidosis who was able to achieve euglycemia despite discontinuation of all antihyperglycemic therapy prior to surgical or medical treatment for his acromegaly. No previous cases of acromegaly presenting in diabetic ketoacidosis have reported glycemic normalization without antihyperglycemic therapy prior to acromegaly treatment. Our case highlights this unique outcome and postulates that pancreatic β-cell resiliency may be influential on insulin resistance since our patient achieved euglycemia despite a persistent state of excess growth hormone and insulin-like growth factor-1. Our case further emphasizes that consideration for acromegaly should be given in patients presenting with severe insulin resistance and pertinent medical history and physical examination features, and it emphasizes the dramatic range of insulin requirements in patients with acromegaly. Oxford University Press 2022-11-29 /pmc/articles/PMC10578379/ /pubmed/37908250 http://dx.doi.org/10.1210/jcemcr/luac007 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Case Report Goldstein, Michael B Bellavia, Lauren Kurian, Tiffany Klek, Stanislaw Insulin Requirements in Untreated Acromegaly: From 200 to 0 |
title | Insulin Requirements in Untreated Acromegaly: From 200 to 0 |
title_full | Insulin Requirements in Untreated Acromegaly: From 200 to 0 |
title_fullStr | Insulin Requirements in Untreated Acromegaly: From 200 to 0 |
title_full_unstemmed | Insulin Requirements in Untreated Acromegaly: From 200 to 0 |
title_short | Insulin Requirements in Untreated Acromegaly: From 200 to 0 |
title_sort | insulin requirements in untreated acromegaly: from 200 to 0 |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578379/ https://www.ncbi.nlm.nih.gov/pubmed/37908250 http://dx.doi.org/10.1210/jcemcr/luac007 |
work_keys_str_mv | AT goldsteinmichaelb insulinrequirementsinuntreatedacromegalyfrom200to0 AT bellavialauren insulinrequirementsinuntreatedacromegalyfrom200to0 AT kuriantiffany insulinrequirementsinuntreatedacromegalyfrom200to0 AT klekstanislaw insulinrequirementsinuntreatedacromegalyfrom200to0 |